PL2029121T3 - Transdermalny system terapeutyczny zawierający cząstki substancji czynnej, o zwiększonym przepływie substancji czynnej - Google Patents

Transdermalny system terapeutyczny zawierający cząstki substancji czynnej, o zwiększonym przepływie substancji czynnej

Info

Publication number
PL2029121T3
PL2029121T3 PL07725656T PL07725656T PL2029121T3 PL 2029121 T3 PL2029121 T3 PL 2029121T3 PL 07725656 T PL07725656 T PL 07725656T PL 07725656 T PL07725656 T PL 07725656T PL 2029121 T3 PL2029121 T3 PL 2029121T3
Authority
PL
Poland
Prior art keywords
active ingredient
therapeutic system
transdermal therapeutic
flux
water
Prior art date
Application number
PL07725656T
Other languages
English (en)
Inventor
Michael Horstmann
Mohammad Sameti
Tobias Jung
Original Assignee
Lts Lohmann Therapie Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38520773&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2029121(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lts Lohmann Therapie Systeme Ag filed Critical Lts Lohmann Therapie Systeme Ag
Publication of PL2029121T3 publication Critical patent/PL2029121T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07725656T 2006-06-08 2007-05-30 Transdermalny system terapeutyczny zawierający cząstki substancji czynnej, o zwiększonym przepływie substancji czynnej PL2029121T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006026578A DE102006026578B4 (de) 2006-06-08 2006-06-08 Wirkstoffpartikelhaltiges Transdermales Therapeutisches System mit erhöhtem Wirkstofffluss und Verfahren zu seiner Herstellung sowie Verwendung
PCT/EP2007/004765 WO2007140909A1 (de) 2006-06-08 2007-05-30 Wirkstoffpartikelhaltiges transdermales therapeutisches system mit erhöhtem wirkstofffluss
EP07725656A EP2029121B1 (de) 2006-06-08 2007-05-30 Wirkstoffpartikelhaltiges transdermales therapeutisches system mit erhöhtem wirkstofffluss

Publications (1)

Publication Number Publication Date
PL2029121T3 true PL2029121T3 (pl) 2010-06-30

Family

ID=38520773

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07725656T PL2029121T3 (pl) 2006-06-08 2007-05-30 Transdermalny system terapeutyczny zawierający cząstki substancji czynnej, o zwiększonym przepływie substancji czynnej

Country Status (13)

Country Link
US (2) US10292942B2 (pl)
EP (1) EP2029121B1 (pl)
JP (1) JP5757682B2 (pl)
CN (1) CN101466361B (pl)
AT (1) ATE459345T1 (pl)
BR (1) BRPI0712420A2 (pl)
CA (1) CA2652216C (pl)
DE (2) DE102006026578B4 (pl)
DK (1) DK2029121T3 (pl)
ES (1) ES2340732T3 (pl)
PL (1) PL2029121T3 (pl)
PT (1) PT2029121E (pl)
WO (1) WO2007140909A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006026578B4 (de) * 2006-06-08 2009-01-08 Lts Lohmann Therapie-Systeme Ag Wirkstoffpartikelhaltiges Transdermales Therapeutisches System mit erhöhtem Wirkstofffluss und Verfahren zu seiner Herstellung sowie Verwendung
US8369942B2 (en) * 2008-03-20 2013-02-05 The Invention Science Fund I, Llc Subdermal material delivery device
CA2662499A1 (en) 2008-04-16 2009-10-16 Nitto Denko Corporation Transdermal drug administration device
US20110033545A1 (en) * 2009-08-06 2011-02-10 Absize, Inc. Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith
DE102011100619A1 (de) 2010-05-05 2012-01-05 Amw Gmbh Transdermales therapeutisches System (TTS) mit einem Gehalt an einem Opiod-Analgetikum
ES2769576T3 (es) 2010-08-23 2020-06-26 Fraunhofer Ges Forschung Partículas humidificadas que comprenden una sustancia terapéuticamente activa
DE102011090178A1 (de) * 2011-12-30 2013-07-04 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit geringer Neigung zur Spontankristallisation
DK2810646T3 (en) 2013-06-04 2016-10-31 Lts Lohmann Therapie Systeme Ag A transdermal
CN107072886A (zh) 2014-10-21 2017-08-18 宝洁公司 用于改善皮肤外观的试剂盒
CN104758181A (zh) * 2015-04-09 2015-07-08 史祎 一种无溶剂贴敷剂制备工艺
EP3365066B1 (en) 2015-10-22 2019-11-20 The Procter and Gamble Company Barrier patch of a foamed film and methods of improving skin appearance
WO2017070082A1 (en) 2015-10-22 2017-04-27 The Procter & Gamble Company Barrier patch of a foamed film and methods of improving skin appearance
US10857076B2 (en) 2017-01-09 2020-12-08 The Procter & Gamble Company Barrier patch with soluble film and methods of improving skin appearance
CN110167642B (zh) 2017-01-09 2022-06-07 宝洁公司 具有可溶性膜的阻隔贴片和改善皮肤外观的方法
US10751265B2 (en) * 2017-01-09 2020-08-25 The Procter & Gamble Barrier patch with soluble film and methods of improving skin appearance
WO2018237214A1 (en) * 2017-06-22 2018-12-27 The Procter & Gamble Company BEAUTY MASK FILMS COMPRISING A WATER SOLUBLE LAYER AND A VACUUM EVAPORATED COATING
KR102524880B1 (ko) * 2017-12-21 2023-04-21 한양대학교 산학협력단 하이드로콜로이드 조성물 및 이를 포함하는 바이오 패치
WO2019183010A1 (en) 2018-03-19 2019-09-26 The Procter & Gamble Company Method of making a barrier patch with soluble film
US20220280443A1 (en) * 2021-03-08 2022-09-08 Nikita Patel Transdermal Delivery System

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3964482A (en) 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
US3965482A (en) * 1974-11-12 1976-06-22 Rca Corporation Velocity correction circuit for video discs
US4460372A (en) 1981-02-17 1984-07-17 Alza Corporation Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer
US4687481A (en) * 1984-10-01 1987-08-18 Biotek, Inc. Transdermal drug delivery system
DE3587616D1 (de) * 1984-12-22 1993-11-11 Sanol Arznei Schwarz Gmbh Wirkstoffpflaster.
GB8629640D0 (en) 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
US5059189A (en) 1987-09-08 1991-10-22 E. R. Squibb & Sons, Inc. Method of preparing adhesive dressings containing a pharmaceutically active ingredient
IT1230566B (it) 1988-10-17 1991-10-28 Vectorpharma Int Farmaci poco solubili supportati su sostanze polimeriche in forma atta all'aumento della velocita' di dissoluzione
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
US5270358A (en) * 1989-12-28 1993-12-14 Minnesota Mining And Manufacturing Company Composite of a disperesed gel in an adhesive matrix
IT1243745B (it) * 1990-10-17 1994-06-21 Vectorpharma Int Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
DE4332093C2 (de) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung
JPH0912448A (ja) * 1995-04-28 1997-01-14 Read Chem Kk 薬物放出制御型経皮吸収製剤
US6238700B1 (en) * 1995-12-01 2001-05-29 Alza Corporation Method for preventing crystal formation in a dispersion of a liquid in a matrix
DE19652196A1 (de) 1996-12-16 1998-06-18 Jenapharm Gmbh Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen
ES2163138T3 (es) * 1997-10-06 2002-01-16 Adalbert Raps Stiftung Procedimiento para fabricar un producto en forma de polvo a partir de una sustancia liquida o de una mezcla de sustancias.
DE19844079A1 (de) * 1998-05-22 1999-11-25 Novosis Pharma Ag Biphasische Transdermalsysteme
DE19906152B4 (de) 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
FI20010115A0 (fi) * 2001-01-18 2001-01-18 Orion Corp Menetelmä nanopartikkelien valmistamiseksi
DE10136784A1 (de) * 2001-07-27 2003-02-20 Lohmann Therapie Syst Lts Darreichungsformen mit wirkstoffhaltigen Partikeln, zur Anwendung auf der Haut oder Schleimhaut
DE10234673B4 (de) 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
DE102006026578B4 (de) * 2006-06-08 2009-01-08 Lts Lohmann Therapie-Systeme Ag Wirkstoffpartikelhaltiges Transdermales Therapeutisches System mit erhöhtem Wirkstofffluss und Verfahren zu seiner Herstellung sowie Verwendung

Also Published As

Publication number Publication date
ES2340732T3 (es) 2010-06-08
CN101466361A (zh) 2009-06-24
PT2029121E (pt) 2010-05-11
CN101466361B (zh) 2012-01-04
US20090258062A1 (en) 2009-10-15
EP2029121A1 (de) 2009-03-04
DK2029121T3 (da) 2010-06-07
US10596126B2 (en) 2020-03-24
DE102006026578B4 (de) 2009-01-08
EP2029121B1 (de) 2010-03-03
CA2652216A1 (en) 2007-12-13
US10292942B2 (en) 2019-05-21
ATE459345T1 (de) 2010-03-15
WO2007140909A1 (de) 2007-12-13
BRPI0712420A2 (pt) 2012-09-04
US20190231710A1 (en) 2019-08-01
JP2009539786A (ja) 2009-11-19
DE102006026578A1 (de) 2007-12-13
JP5757682B2 (ja) 2015-07-29
DE502007003020D1 (de) 2010-04-15
CA2652216C (en) 2016-02-16

Similar Documents

Publication Publication Date Title
PL2029121T3 (pl) Transdermalny system terapeutyczny zawierający cząstki substancji czynnej, o zwiększonym przepływie substancji czynnej
WO2010125475A3 (en) Sustained release formulations comprising gnrh analogues
WO2012040623A3 (en) Nanostructured gels capable of controlled release of encapsulated agents
WO2008087215A3 (en) Partially bioabsorbable implant
MX362838B (es) Composiciones farmacéuticas de liberación prolongada para disuadir el abuso de opioides que comprenden un plastómero, un elastómero y un plastificante delicuescente.
CY1109606T1 (el) Βιοδιασπωμενο υμενιο για την απελευθερωση φαρμακου στον οφθαλμο
WO2007000778A3 (en) Modified release pharmaceutical compositions on the basis of two polymers and processes thereof
WO2009117130A3 (en) Extended release forumulation containing a wax
WO2005120393A3 (en) Implantable device for drug delivery and improved visibility
MX362357B (es) Forma de dosificacion farmaceutica resistente a la adulteracion y resistente a la liberacion inmediata de la dosis.
TW200727919A (en) Guaifenesin sustained release formulation and tablets
PT2043600T (pt) Formulações farmacêuticas para a libertação prolongada de princípio(s) ativo(s), assim como suas aplicações, nomeadamente terapêuticas
WO2006099514A3 (en) Drug delivery compositions and related methods
WO2006094113A3 (en) Mask container
MX359119B (es) Formulaciones de liberación sostenida para el suministro de proteínas al ojo y métodos para prepararlas.
WO2010061288A3 (en) Polymeric pharmaceutical dosage form in sustained release
WO2010100650A3 (en) Therapeutic uses of mastic gum fractions
WO2008067164A3 (en) Solid pharmaceutical dosage formulations
EP2589379A4 (en) TRANSDERMAL AGGREGATE FREEZING SYSTEM WITH DONEPEZIL
WO2012048176A3 (en) Attachment and retention formulations for biologically active organic compounds
WO2007017331A3 (en) Immediate release therapeutic systems for improved oral absorption of 7- [ (e) -tert-butyloxyiminomethyl] camptothecin
WO2012085284A3 (en) High drug load pharmaceutical formulations comprising dronedarone and its pharmaceutically acceptable salts
WO2008101173A3 (en) Biodegradable compositions and materials
WO2012172433A3 (en) A sustained -release composition containing a melanocortin receptor ligand as the active ingredient
MX2023003556A (es) Composiciones farmaceuticas.